Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,660,224
-$252,084 QoQ
Shares Held
58,666
+8.4% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#140
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VAN ECK ASSOCIATES CORP holds $344,568,608 across 24 Biotechnology names. ALNY ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
143,881 | $71,470,008 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,332 | $40,737,114 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
111,381 | $20,859,433 | |
| 4 | TECH |
BIO-TECHNE Corp
|
293,165 | $20,712,105 | |
| 5 | ARGX |
Argenx SE
|
22,193 | $20,589,999 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
58,666 | $17,660,224 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
307,103 | $17,572,433 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
55,002 | $15,673,919 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,660,224 | 58,666 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,912,308 | 54,137 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,056,183 | 47,922 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $18,756,648 | 41,133 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $17,791,469 | 54,560 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $17,320,162 | 64,144 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $15,958,252 | 67,818 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $15,786,446 | 57,399 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $14,807,934 | 60,938 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $8,656,591 | 57,923 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $11,720,608 | 61,233 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $12,589,330 | 71,086 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $14,809,241 | 77,968 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $16,282,209 | 81,281 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $21,954,106 | 92,380 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $13,990,382 | 69,896 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $15,962,115 | 109,442 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $16,329,979 | 100,006 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $16,722,962 | 98,614 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $17,502,875 | 92,701 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $20,447,841 | 120,622 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $14,154,862 | 100,254 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $13,676,613 | 105,229 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $12,585,518 | 86,439 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $16,439,913 | 110,998 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $9,470,385 | 87,004 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||